Activation trajectories of integrin α5β1
整合素 α5α1 的激活轨迹
基本信息
- 批准号:10320795
- 负责人:
- 金额:$ 73.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-20 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAdhesionsAffectAffinityAmino AcidsAtherosclerosisAwardBindingBinding ProteinsBinding SitesBiological ProcessBlood CellsCell AdhesionCell CommunicationCell Surface ProteinsCell Surface ReceptorsCell surfaceCellsCouplingCytoskeletonDataDiseaseDisputesDissociationDisulfidesDivalent CationsEnvironmentEquilibriumErythropoiesisEventExtracellular MatrixFibronectinsFibrosisFluorescence Resonance Energy TransferFree EnergyGrantHematopoiesisIntegrin BindingIntegrin alpha5beta1Integrin beta ChainsIntegrinsIonsKineticsKneeLigand BindingLigandsLightLinkMalignant NeoplasmsMapsMeasurementMeasuresMediatingMetal Ion BindingMetalsMolecular ConformationMutateMutationPathologyPlayPopulationPositioning AttributeReactionReportingResearchRestRoleShapesSickle Cell AnemiaSiteStructureSupporting CellTestingTissuesTitrationsTotal Internal Reflection FluorescentTransmembrane DomainWorkbasecell motilityconformational conversioncyanine dye 5drug developmentexperimental studyextracellularfluorophoreinsightmonocyterate of changesingle moleculetemporal measurementtool
项目摘要
Abstract.
Integrins are cell surface receptors that mediate numerous interactions between cells and their environment.
Binding of integrin α5β1 to its ligand fibronectin in the extracellular matrix plays fundamental roles in cellular
adhesion and differentiation. In blood cells these interactions mediate biological processes including
erythropoiesis and monocyte adhesion and contribute to pathologies such as sickle cell disease, dysregulation
of hematopoiesis, atherosclerosis, and fibrosis. Integrin α5β1 undergoes two distinct conformational changes:
extension at the ‘knees’ and opening of the ligand-binding headpiece. These changes give rise to an ensemble
of three interconverting integrin conformational states on cell surfaces: low-affinity bent-closed (BC) and
extended-closed (EC) conformations and a high-affinity extended-open (EO) conformation. This proposal
leverages ground-breaking work under the previous award in which we measured free energy and intrinsic
affinity of each integrin α5β1 state. Using the same Fab tools as used for these equilibrium measurements to
stabilize the extended, closed, or open α5β1 conformations, we now propose three aims. In Aim 1, we explore
how Mn2+, high Mg2+, and low Ca2+ concentrations activate integrins. Our preliminary results show that Mn2+
and high Mg2+ both increase the population of the EO state and increase its intrinsic affinity for ligand and that
these effects are dependent on the ADMIDAS metal-ion binding site. To examine why cell surface α5β1 is so
stable in the BC state, we test the hypothesis that the α and β-subunit TM domains separate from one another
in both the EC and EO states. Aims 2 and 3 measure kinetics to map the activation trajectory of integrin α5β1,
i.e. the sequence of ligand binding and conformational change events that occur between the resting state,
when 99.8% of unliganded integrin α5β1 is in the BC state, and the final, functional liganded EO state (EO•L)
state that is bound to fibronectin and is stabilized by tensile force that is applied to the integrin by actin
retrograde flow and resisted by fibronectin in the matrix. In Aim 2, we measure the intrinsic ligand-binding
kinetics of each state (kon and koff). Our preliminary data indicates, surprisingly, that the low-affinity BC and EC
states bind more rapidly to ligand than the EO state, which is compensated by the >10,000-fold slower off-rate
of the EO state. In Aim 3, we measure the kinetics of integrin conformational change using single-molecule
FRET probes that measure either the extension or opening steps in the presence or absence of conformation-
specific Fabs and ligand. Kinetics of all transitions between the BC, EC, and EO states for unliganded and
ligand-bound single integrin molecules will be determined for both purified, soluble ectodomain and intact
integrins on blood cells using TIRF microscopy with high temporal resolution. We expect to show an integrin
activation trajectory in which ligand binds to the BC+EC states, followed by ligand-facilitated conformational
conversion to the EO•L state, followed by cytoskeletal adaptor (A) binding and stabilization of the EO•L•A state
by force applied by the cytoskeleton and resisted by extracellular ligand.
抽象的。
整联蛋白是细胞表面受体,可介导细胞及其环境之间的大量相互作用。
整联蛋白α5β1与其在细胞外基质中的配体纤连蛋白的结合在细胞中起基本作用
粘附和分化。在血细胞中,这些相互作用媒体生物过程包括
红细胞生成和单核细胞粘合剂并导致镰状细胞病,失调等病理
造血,动脉粥样硬化和纤维化。整合素α5β1经历了两个不同的构象变化:
在“膝盖”和配体结合头饰的打开处延伸。这些变化引起了合奏
在细胞表面上的三个相互转化的整联蛋白构象状态:低亲和力弯曲(BC)和
扩展闭合(EC)构象和高亲和力扩展(EO)构象。这个建议
在上一个奖项下,我们测量了自由能和内在的奖项,利用了上一项奖项的开创性工作
每个整合素α5β1状态的亲和力。使用与这些平衡测量相同的工具工具
稳定扩展,封闭或开放的α5β1构象,我们现在提出三个目标。在AIM 1中,我们探索
MN2+,高Mg2+和低Ca2+浓度如何激活整联蛋白。我们的初步结果表明MN2+
高MG2+都增加了EO状态的人口,并增加了对配体的内在亲和力,并且
这些作用取决于Admidas Metal-Ion结合位点。检查为什么细胞表面α5β1如此
在卑诗省状态下,我们测试了α和β-亚基TM域彼此分开的假设
在EC和EO国家中。目标2和3测量动力学来绘制整合素α5β1的激活轨迹,
即配体结合和构象变化事件的序列,在静止状态之间发生,
当99.8%的非配体整联蛋白α5β1处于BC状态时,最终的功能性配体EO状态(EO•L)
与纤连蛋白结合并通过肌动蛋白应用于整联蛋白的拉伸力稳定的状态
逆行流动,并由基质中的纤连蛋白抵抗。在AIM 2中,我们测量固有的配体结合
每个州的动力学(Kon和Koff)。我们的初步数据表明,低亲和力BC和EC
与EO状态相比,状态与配体更快地结合,EO状态被速度慢10,000倍弥补
eo状态。在AIM 3中,我们使用单分子测量整联蛋白构象变化的动力学
在存在或不存在构象的情况下测量延伸或开放步骤的有点问题 -
特定的晶圆厂和配体。卑诗省,EC和EO国家之间所有过渡的动力学
将确定纯化的,可溶性外域和完整的结合配体单一整合素分子
使用具有高临时分辨率的TIRF显微镜在血细胞上的整合素。我们希望展示一个整合素
配体与BC+EC状态结合的激活轨迹,其次是配体辅助构象
转换为EO•L状态,然后转换为细胞骨架适配器(a)EO•l•a•a•a的结合和稳定
通过细胞骨架施加的力并由细胞外配体抵抗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TIMOTHY A SPRINGER其他文献
TIMOTHY A SPRINGER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TIMOTHY A SPRINGER', 18)}}的其他基金
Structural basis of von Willebrand factor biology and physics
冯维勒布兰德因子生物学和物理学的结构基础
- 批准号:
10198035 - 财政年份:2019
- 资助金额:
$ 73.43万 - 项目类别:
Structural basis of von Willebrand factor biology and physics
冯维勒布兰德因子生物学和物理学的结构基础
- 批准号:
10434710 - 财政年份:2019
- 资助金额:
$ 73.43万 - 项目类别:
Structures and Conformational Equilibria of Integrin alpha5 beta1
整合素α5β1的结构和构象平衡
- 批准号:
9079774 - 财政年份:2016
- 资助金额:
$ 73.43万 - 项目类别:
Structures and Conformational Equilibria of Integrin alpha5 beta1
整合素α5β1的结构和构象平衡
- 批准号:
9265127 - 财政年份:2016
- 资助金额:
$ 73.43万 - 项目类别:
Structural mechanisms underlying latency and activation of GDF8
GDF8 潜伏期和激活的结构机制
- 批准号:
9302311 - 财政年份:2016
- 资助金额:
$ 73.43万 - 项目类别:
Structural mechanisms underlying latency and activation of GDF8
GDF8 潜伏期和激活的结构机制
- 批准号:
9175103 - 财政年份:2016
- 资助金额:
$ 73.43万 - 项目类别:
相似国自然基金
动脉粥样硬化发生中CAPN2影响内皮粘连的机制研究
- 批准号:82000254
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
层粘连蛋白调控巨噬细胞和脂肪基质细胞影响肥胖脂肪组织重塑的机制
- 批准号:
- 批准年份:2019
- 资助金额:300 万元
- 项目类别:
层粘连蛋白受体第272位苏氨酸影响猪瘟病毒感染的分子机制
- 批准号:31902264
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
大黄-桃仁介导AhR通路影响Th17/Treg和肠道菌群平衡改善肠粘膜屏障功能防治粘连性肠梗阻的机制研究
- 批准号:81804098
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
保留双层肌膜的功能性肌肉移植中S1P/S1PR1轴调节巨噬细胞迁移及分化对移植肌肉粘连与功能的影响
- 批准号:81871787
- 批准年份:2018
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Full Project 1: Defining Mechanisms of MICAL-dependent Pancreatic Cancer Cell Migration
完整项目 1:MICAL 依赖性胰腺癌细胞迁移的定义机制
- 批准号:
10762273 - 财政年份:2023
- 资助金额:
$ 73.43万 - 项目类别:
Role of myosin 1e in podocyte biology and renal filtration
肌球蛋白 1e 在足细胞生物学和肾滤过中的作用
- 批准号:
10587345 - 财政年份:2023
- 资助金额:
$ 73.43万 - 项目类别:
Predictive multi-scale model of focal adhesion-based durotaxis
基于粘着斑的 durotaxis 的预测多尺度模型
- 批准号:
10798520 - 财政年份:2023
- 资助金额:
$ 73.43万 - 项目类别:
Project 1: Defining Mechanisms of MICAL-dependent Pancreatic Cancer Cell Migration
项目 1:定义 MICAL 依赖性胰腺癌细胞迁移机制
- 批准号:
10762144 - 财政年份:2023
- 资助金额:
$ 73.43万 - 项目类别:
Dissecting the Molecular Link Between Stroke, Actin, and Alzheimer's Disease
剖析中风、肌动蛋白和阿尔茨海默病之间的分子联系
- 批准号:
10772704 - 财政年份:2023
- 资助金额:
$ 73.43万 - 项目类别: